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Some antimicrobial peptides (AMPs), microRNAs (miRs), and Toll-like receptor 4 (TLR-4) are 
involved in autoimmune diseases, which may be affected by exercise training. The purpose of this 
study was to investigate the effect of an eight-week combined exercise training (aerobic and 
resistance) on the expression of inflammatory factors, including, human beta-defensin-2 (hBD-2), 
cathelicidin (LL-37), TLR-4, miR-23b, miR-155, and miR-326 in women with relapsing and 
remitting multiple sclerosis (RRMS), which has not been investigated yet. 
Twenty-three women (20-40 years) with RRMS were randomized into the combined training 
(CT) and control (CON) groups. The CT group subjects completed eight weeks of supervised CT 
using a treadmill and stationary bicycle for aerobic exercise and weight machines for resistance 
exercise. The expression levels of hBD-2, LL-37, TLR-4, miR-23b, miR-155, and miR-326 were 
measured by real-time polymerase chain reaction (RT-PCR) at the baseline and end of the study.  
Although the expression of hBD-2 and miR-23b decreased in both CT and CON groups, the 
reduction was lower in the CT group than in the CON group (p=0.001). The expression of LL-37 
in the CT group remained unchanged, but that of the CON group increased; thus, the between-
group difference was significant. Although the TLR-4, miR-155, and miR-326 expression 
increased in both groups compared to the baseline, the increase in the CT group was lower than 
the CON group. 
Our results showed that the combined training might improve inflammatory symptoms by 
affecting the expression of some AMPs, miRs, and TLR-4 in patients with relapsing and remitting 
multiple sclerosis. 
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Multiple sclerosis (MS) is associated with the 
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inflammatory demyelination of the central nervous 
system.1 Some genetic and immunological factors 
contribute to the development and progression of MS. 
Moreover, the physical inactivity that is common 
among people with MS, as an environmental factor 
may have a significant role in the disease process.2,3 
Exercise training can have beneficial effects for 
patients with MS, and it may improve MS-related 
inflammation through the favorable changes in the 
antimicrobial peptides (AMPs), microRNAs (miRs), 
and Toll-like receptor 4 (TLR-4). In this regard, 
recently, it has been reported that the combined training 
(CT; aerobic, and resistance) has positive effects on 
muscle strength, endurance, some inflammatory 
factors, and fatty tissue in MS patients.4-8 
Antimicrobial peptides have a significant role in the 
innate immune system and may contribute to 
neurodegenerative diseases.9 Cathelicidin )LL-37( and 
human beta‐defensin‐2 (hBD-2) are two AMPs that 
serve as innate immunity components, they are 
considered next-generation antibiotics,10,11 and their 
overexpression can be associated with autoimmune 
diseases.12,13 Besides their antimicrobial activity, also 
these peptides are known as immune modulators.10 
hBD-2 acts as a primary immune factor within the 
central nervous system (CNS), and it is induced by pro-
inflammatory stimuli or microorganisms.9,14 Expression 
of the hBD-2 can be triggered by bacteria-derived 
molecules, immune system, cytokines such as 
interleukin (IL)-17, and damaged cells.15 Excessive 
expression level of IL-17 has been detected in the brain 
in MS patients.16 LL-37 may interact with the innate 
immune response.17 LL-37 may trigger pro-
inflammatory signals, and exposure to it can recruit 
inflammatory cells.13 Considering the LL-37 sequence 
and lipopolysaccharides (LPS) exposure, the effects of 
LL-37 on TLR-4 can be pro-inflammatory.18 TLR-4 
plays a key role in pathogen recognition and activation 
of various inflammatory signaling pathways.19 TLR-4 
regulates the autoimmune responses, and its 
overexpression can result in the development of 
neurological diseases.20 
Several miRNAs regulate Toll-like receptor (TLR) 
signaling by targeting MyD88,21 and some autoimmune 
diseases are associated with the change in miRs.22,23 
MS patients have a dysregulated miRs, and even minor 
changes in the miRs expression may lead to significant 
alterations in gene expression.24 The severity of MS is 
directly related to the expression levels of miR-155, 
miR-326, and miR-23b.25-27 The up-regulation of miR-
155 and miR-326 as pro-inflammatory miRs, and the 
down-regulation of miR-23b as anti-inflammatory 
miRs can lead to inflammation.24 The miR-23b 
expression is remarkably low in MS-associated 
inflammatory lesions.27,28 The miR-155 expression is 
up-regulated in the brain lesions in patients with MS 
and is involved in inflammation.29-31 The miR-326 
expression correlates with autoimmune diseases, and its 
expression level in peripheral blood mononuclear cells 
is significantly higher in the MS patients compared to 
healthy people and MS patients at the recovery 
stage.25,32 TLR-4 expression is directly related to the 
miR-155 expression33 and inversely related to the miR-
23b expression.21 Moreover, it has been reported that 
the expression levels of IL-17 are inversely associated 
with miR-23b expression and directly with miR-326.25 
Although several studies reported that acute 
exercise (a single session) increases hBD-234,35 and LL-
37,34,36,37 no chronic (long-term) exercise training 
studies have been conducted regarding hBD-2 and LL-
37. However, a study has shown that TLR-4 expression 
increases after a 2-week high-intensity interval 
training,38 some studies have reported that the 
expression of TLR-4 decreases after several weeks of 
exercise training.39-41 Moreover, a few studies have 
examined the changes of miRs in response to exercise 
training in patients and none in MS patients. Therefore, 
to the best of our knowledge, the effects of exercise 
training on the expression of antimicrobial peptides, 
microRNAs, and TLR-4 have not been studied on MS. 
Thus, the purpose of this study was to determine if an 
eight-week combined training would attenuate 
inflammation in women with relapsing-remitting 
multiple sclerosis (RRMS) by affecting the hBD-2, LL-
37, TLR-4, miR-23b, miR-155, and miR-326.  
 
MATERIALS AND METHODS 
 
Participants 
Ninety women patients with RRMS expressed an 
interest in participating in this study. Forty-eight 
volunteers did not meet the inclusion criteria, and 18 
volunteers withdrew from the study due to personal 
reasons. After baseline testing, the subjects were 
stratified for Expanded Disability Status Scale (EDSS) 
score and age, and then randomly assigned to either a 
combined training (CT) group (n=12) or a control 
(CON) group (n=12). One subject of the CON group 
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dropped out due to personal reasons, and so 23 patients 
remained for the final analysis (CT group, n=12 and 
CON group, n=11) (Figure 1). The sample size was 
calculated based on the results of the effect of eight 
weeks of combined exercise training on women with 
multiple sclerosis.7 An alpha error of 5%, a beta error of 
90%, and an effect size of 0.40 were considered for 
study groups. According to these parameters and using 
G*Power software (Version 3.1.9.2), a total sample size 
of 20 subjects was calculated. The sample size was taken 
into account by 24 participants (12 subjects in each 
group) to accord with an anticipated 20% dropout rate. 
The main inclusion criteria were: (a) confirmed 
diagnosis of RRMS, (b) an EDSS of 1-4, (c) no 
corticosteroid therapy within the last three months, (d) 
ability to participate in the exercise, (e) no exercise 
training within the last six months, and (f) the age 
range of 20-40 years. The exclusion main criteria were: 
(a) exacerbation of MS and (b) corticosteroid therapy 
during the study period. 
All participants gave their informed consent before 
their inclusion in the study. They were informed of the 
benefits and risks of the investigation before signing 
consent. This study was approved by the research 
ethics committee of the Sport Sciences Research 
Institute (IR.SSRC.REC.1398.071). Furthermore, we 
have registered this study in the Iranian Registry of 
Clinical Trials (IRCT20191006045004N1). 
Combined Training Protocol 
The CT group completed four supervised exercise 
sessions per week (three aerobic and one-resistance 
sessions) for eight weeks (Table 1). The CON group 
did not perform any exercise during the study period. 
All training sessions were conducted in the morning at 
22 to 24°C and relative humidity of 55% to 65%.5 
Exercise intensity was monitored according to the 
exercise protocol using ratings of perceived exertion 
(very light=9 to moderate=13). 
 
Aerobic Exercise 
Participants walked/ran on a treadmill and/or pedaled 
on a stationary bicycle at an intensity level of 40 (first 
week) to 70 (eighth week) percent of maximum heart 
rate (HRmax)6,7 (Table 1). The HRmax was estimated using 
the equation: HRmax=220–age and was applied to 
determine the intensity of aerobic exercise for each 
session. Heart rate was monitored; using a Polar heart 
rate monitor (RCX5, Kempele, Finland). 
 
Resistance Exercise 
Participants performed resistance exercise (knee 
flexion and extension) at an intensity level of 50 (first 
week) to 70 (eighth week) percent of one repetition 





Figure 1. Flow chart of the study. CT: combined training; CON: control. 
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Table 1. Combined training protocol 
Weeks 
Aerobic exercise Resistance exercise 
Cycling† Rest (min) 
Walking on 
treadmill† 
Knee extension‡ Rest (min) 
Knee  
flexion 
1 10 min at 40% 10 10 min at 40% 3×10, 50% 5 3×10, 50% 
2 10 min at 50% 10 10 min at 50% 3×10, 55% 5 3×10, 55% 
3 15 min at 50% 10 15 min at 50% 3×10, 60% 5 3×10, 60% 
4 15 min at 55% 10 15 min at 55% 3×10, 60% 5 3×10, 60% 
5 15 min at 55% 10 15 min at 55% 3×10, 65% 5 3×10, 65% 
6 20 min at 55% 10 20 min at 55% 3×10, 65% 5 3×10, 65% 
7 20 min at 60% 10 20 min at 60% 3×10, 70% 5 3×10, 70% 
8 20 min at 70% 10 20 min at 70% 3×10, 70% 5 3×10, 70% 
†Intensity is expressed as a percentage of maximal heart rate (HRmax). ‡Intensity is expressed as a percentage of one-repetition 
maximum (1RM). 
 
Anthropometric Measurements, Blood Analysis, 
and EDSS Evaluation 
Subjects completed a standard anthropometric 
assessment of height, weight, and BMI. Blood samples 
(3 mL) were obtained from the antecubital vein at 
baseline and 48 hours after the last exercise session 
using standard procedures. EDSS was scored by our 
colleague (Dr. Nahid Jivad) as a neurologist with 
experience in MS, before and after the eight-week 
exercise program. 
 
Evaluation of mRNA and MicroRNA Expression 
Levels 
The expression levels of mRNAs and miRs were 
measured; using the real-time polymerase chain 
reaction (RT-PCR) technique following RNA 
extraction and cDNA synthesis. Total RNA extraction 
was performed using Iraizol extraction kits (RNA 
Biotech, Co, Isfahan, Iran) according to the 
manufacturer’s manual. Briefly, 1 mL of RNA 
extraction buffer (Iraizol, RNA Biotech, Co, Isfahan, 
Iran) was added to 700 μL of the blood sample. The 
mixture then incubated at room temperature for 5 
minutes, followed by the addition of 200 μL 
chloroform (Merck, Germany) before being vigorously 
shaken for 10 to 15 seconds. The mixture then was 
incubated at room temperature for 5 minutes, followed 
by 2 minutes centrifugation at 1000 rpm at 4°C, which 
resulted in the formation of two separate layers. The 
top clear layer which contained RNA was carefully 
separated and transferred to a nuclease-free tube 
followed by the addition of 1000 µL of 100% ice-cold 
ethanol (Merck, Germany) and incubation at -20°C for 
15-20 minutes. Finally, the tube was removed from the 
freezer and centrifuged for 8 minutes at 1000 rpm at 
4°C. The supernatant was then discarded and 50 μL of 
RNase-free water was added to the column followed by 
1-minute centrifugation at 10,000 rpm. The obtained 
solution contained extracted RNA. The RNA 
concentration and purity were assessed by measuring 
260/280 nm absorbance on a nano spectrophotometer 
(Epoc, Biotech, USA). The absorbance ratios were 
between 1.6 and 1.9 for all RNA samples, which then 
were stored immediately at -80˚C until further use. 
 
cDNA Synthesis 
cDNA was synthesized using the RB MMLV 
Reverse Transcriptase Kit (RNA biotech, CO, Isfahan, 
Iran) according to the manufacturer's instructions. This 
consisted of mixing 0.5µg RNA and 2 µM Oligo (dT) 
Primer in a 0.25 ml nuclease-free Eppendorf tube. 
Then, DEPC-Treated water was used to bring the 
volume up to 10 µL. The mixture was then gently 
mixed and heated at +65˚C for 10 minutes in a Biorad 
technology thermocycler (USA). Eppendorf tubes were 
placed rapidly on ice for 8 to 10 minutes. Followingly, 
4 µL RT buffer (5X) and 1 μL (200 unit) reverse 
transcriptase enzyme were added to each tube and 
mixed gently by pipetting up and down. Samples were 
shortly spun and finally incubated at +50˚C for 50 min 
followed by a 15-minute incubation at +72˚C to stop 
the cDNA synthesis reaction. The obtained cDNAs 
then were stored at -20˚C until further use. 
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Primer Design  
The primers targeting hBD-2, LL-37, TLR-4, mir-
155, miR-326, and miR-23b were designed using Oligo 
software. A BLAST search was carried out for each 
primer (https://blast.ncbi.nlm.nih.gov/Blast.cgi) to 
check for sequence specificity. Moreover, the cDNAs 
encoding GAPDH and miR-U6 were used as the 
internal control for the normalization of mRNAs and 
miRs expression in RT-PCR, respectively (Table 2). 
All experiments were performed in biological 
triplicate and technical duplicate. For each sample, 12.5 
µl RB s3p SYBR Green Master Mix (2X) (RNA 
biotech, Co, Isfahan, Iran) was added to 10 pmol of 
each forward and reverse primer (Table 2) and 100 ng 
cDNA, and the final volume was increased up to 25 μL 
by the addition of ddH2O. Finally, nuclease-free water 
was used to reach the desired volume. This mixed in 
sterile 0.25 mL microtubes (Applied Biosystems, USA) 
and then vortexed and gently centrifuged for 1 minute 
in a bench centrifuge. For each sample, 25 µL of the 
above mixture was transferred in triplicate into 0.1 mL 
RT-PCR microtubes (Applied Biosystems, USA), 
which then centrifuged before being loaded into a 
Rotor-Gene 6000 RT-PCR machine (Corbett, USA). 
The RT-PCR conditions were as follows: 95°C for 10 
minutes (Hot start) followed by 45 cycles of 95°C for 
10 seconds (Denaturation), 60°C for 15 seconds 
(Annealing/ extension) 72°C for 20 seconds. 
 
Table 2. The primer sequences of LL-37, hBD-2, TLR-4, miR-155, miR-23b, miR-326, and internal controls (GAPDH and 
miR-U6) 
 
Name Forward Reverse Data Base 
LL-37 GTGACTTCAAGAAGGACGGG-3 5-GGGTAGGGCACACACTAGGA-3 NCBI 
hBD-2 GGTGAAGCTCCCAGCCATCA TATCTTTGGACACCATAGTT NCBI 
TLR-4 CAGAGTTGCTTTCAATGGCATC AGACTGTAATCAAGAACCTGGAGG NCBI 
GAPDH TGAAGGTCGGAGTCAACGGATTTGGT CATGTGGGCCATGAGGTCCACCAC NCBI 
miR-155 UUAAUGCUAAUCGUGAUAGGGGUU - miRBase 
miR-23b AUCACAUUGCCAGGGAUUACCAC - miRBase 
miR-326 CCUCUGGGCCCUUCCUCCAG - miRBase 
miR-U6 GCGCGTCGTGAAGCGTTC GTGCAGGGTCCGAGGT miRBase 
LL-37: cathelicidin; hBD-2: human beta-defensin-2; TLR-4: Toll-like receptor 4; GAPDH: glyceraldehyde-3-phosphate 
dehydrogenase; NCBI: National Center for Biotechnology Information. 
 
Statistical Analysis 
To evaluate the expression levels of cDNAs, the 
RT-PCR results were analyzed; using LinRegPCR 
software. The Ct values of cDNAs were obtained 
followed by calculation of Ct and 2 - ct for all of 
the samples.  
The Shapiro–Wilk test was used to determine the 
normality of the data. A two-way analysis of variance 
(ANOVA) with repeated measures [group (CON group 
and CT group) × time (before and after 8 weeks)] was 
used to analyze the data. When a significant main effect 
was found, paired t-tests were used for post-hoc 
comparisons. Mann–Whitney U and Wilcoxon tests 
were used when the data didn't have a normal 
distribution (BMI and EDSS). The body weight data 
were analyzed by independent t-tests. Data were 
analyzed; using IBM SPSS Statistics 25 and are 
expressed as mean± standard deviation (SD). Statistical 
significance was set at p<0.05. The graphs were plotted 




Bodyweight significantly decreased (p=0.005) in 
the CT group (from 62.21±9.15 to 61.28±9.07 kg), and 
significantly increased (p=0.001) in the CON group 
(from 66.07±8.69 to 67.09±9.25 kg), so there was a 
significant between-group difference (p=0.001) (Table 
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3). No significant between-group differences were 
observed in BMI (p=0.215), after eight weeks of CT 
(Table 3). EDSS significantly decreased (p=0.023) in 
the CT group (from 2.25±1.22 to 1.83±1.09 score), but 
did not change in the CON group significantly 
(p=0.414), and there was a significant difference 
(p=0.015) between groups (Table 3). 
 
Table 3. The effects of eight weeks of combined training on weight, BMI and EDSS 
 CON group CT group 
Pre (n=11) Post (n=11) Pre (n=12) Post (n=12) 
Age (years) 33.18±4.67 - 33.00±5.99 - 
Height (cm) 164.09±5.03 - 163.00±3.33 - 
Weight (kg)# 66.07±8.69 67.09±9.25* 62.21±9.15 61.28±9.07* 
BMI (kg/m2) 24.60±3.60 24.98±3.80 23.40±3.33 23.06±3.32 
EDSS (score)# 2±0.95 2.09±1.02 2.25±1.22 1.83±1.09* 
Values are presented as mean ± SD. CT: combined training; CON: control; Pre: before training intervention; Post: after training 
intervention; BMI: body mass index. EDSS: expanded disability status scale. #Significant difference between CT and CON groups 
(p<0.05). *Significant within-group differences (p<0.05).  
 
hBD-2 
The relative expression level of hBD-2 significantly 
decreased in both groups (CON group: p=0.001, CT 
group: p=0.001) compared to the base (from 7.64±1.35 
to 4.38±1.18 in the CON group and from 9.73±1.58 to 
6.48±1.11 in the CT group), but the reduction was 
lower (p=0.001) in the CT group (33.40%) than in the 
CON group (42.67%) after exercise intervention (Table 
4 and Figure 2). 
 
LL-37 
The relative expression level of LL-37 in the CT 
group did not significantly change (p=0.982, 0.14% 
reduction) following eight weeks of CT; but 
significantly increased in the CON group compared to 
the baseline (p=0.001) (from 7.51±0.73 to 12.17±1.88). 
The between-group difference in LL-37 levels was 
significant (p=0.001), which attributed to a relative 
increase (62.05%) in LL-37 expression in the CON 
group (Table 4 and Figure 2). 
 
TLR-4 
The relative expression level of TLR-4 significantly 
increased in both groups (CON group: p=0.001, CT 
group: p=0.001) compared to the base (from 4.51±1.01 
to 10.38±0.81 in the CON group and from 3.76±0.76 to 
6.07±0.98 in the CT group), but the increase in the CT 
group (61.44%) was significantly (p=0.001) lower than 
in the CON group (130.15%), after eight weeks of CT 
(Table 4 and Figure 2). 
MiR-23b 
The relative expression level of miR-23b 
significantly decreased in both groups (CON group: 
p=0.001, CT group: p=0.001) compared to the base 
(from 8.38±2.42 to 2.66±1.11 in CON group and from 
9.06±1.88 to 5.99±1.52 in the CT group), but the 
reduction was significantly (p=0.001) lower in the CT 
group (33.88%) than in the CON group (68.26%), after 
exercise intervention (Table 4 and Figure 2). 
 
MiR-155 
The relative expression level of miR-155 
significantly increased in both groups (CON group: 
p=0.001, CT group: p=0.012) compared to the base 
(from 5.14±1.30 to 11.21±1.34 in the CON group and 
from 6.01±1.14 to 7.29±0.85 in the CT group), but the 
increase in the CT group (21.30%) was significantly 
(p=0.001) lower than in the CON group (118.09%), 
after eight weeks of CT (Table 4 and Figure 2). 
 
MiR-326 
The relative expression level of miR-326 
significantly increased in both groups (CON group: 
p=0.001, CT group: p=0.001) compared to the base 
(from 3.21±0.76 to 11.64±2.87 in the CON group and 
from 3.75±1.04 to 6.03±1.35 in the CT group), but the 
increase in the CT group (60.80%) was significantly 
(p=0.001) lower than in the CON group (262.62%), 
after eight weeks of CT (Table 4 and Figure 2). 
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Figure 2. Relative expression changes in the hBD-2 (A), LL-37 (B), TLR-4 (C), miR-23b (D), miR-155 (E), and miR-326 (F) in 
RRMS patients after eight weeks of CT intervention. #A significant difference between the CT group and CON group 
(P<0.05). *Within-group significant differences (P<0.05). CT: combined training; CON: control; Pre: before training 
intervention; Post: after training intervention; hBD-2: human beta-defensin-2; LL-37: cathelicidin; TLR-4: Toll-like receptor 
4; RRMS: relapsing and remitting multiple sclerosis. 
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Table 4. Relative expression levels of antimicrobial peptides and miRs in multiple sclerosis patients before and after 8 weeks 
of combined training 
 
CON group CT group Eta-squared 
(η2) Pre (n=11) Post (n=11) Pre (n=12) Post (n=12) 
hBD – 2# 7.64±1.35 4.38±1.18* 9.73±1.58 6.48±1.11* 0.594 
LL – 37# 7.51±0.73 12.17±1.88* 6.97±1.12 6.96±1.57 0.668 
TLR – 4# 4.51±1.01 10.38±0.81* 3.76±0.76 6.07±0.98* 0772 
miR – 23b# 8.38±2.42 2.66±1.11* 9.06±1.88 5.99±1.52* 0.430 
miR – 155# 5.14±1.30 11.21±1.34* 6.01±1.14 7.29±0.85* 0.496 
miR – 326# 3.21±0.76 11.64±2.87* 3.75±1.04 6.03±1.35* 0.523 
Values are presented as mean ± SD. #Significant difference between CT and CON groups (p<0.05). *Significant within-group 
differences (p<0.05). CT: combined training; CON: control; Pre: before training intervention; Post: after training intervention;  




The present study investigated the effects of an 
eight-week CT on some antimicrobial peptides, 
microRNAs, and Toll-like receptor 4 in patients with 
RRMS. We found that the reduced expression of hBD-
2 and miR-23b in the CT group was lower than the 
CON group; the LL-37 expression remained unchanged 
in the CT group (almost constant), but increased in the 
CON group; and the increased expression of TLR-4, 
miR-155, and miR-326 in the CT group was lower than 
the CON group. The unchanged expression of LL-37 
and the low levels of hBD-2, miR-23b, TLR-4, miR-
155, and miR-326 in the CT group, can be attributed to 
the effects of CT; however further studies are necessary 
to confirm these results. 
Some studies have demonstrated that exercise 
training reduces systemic inflammation.42,43 Moreover, 
acute exercise up‐regulates pro‐inflammatory genes, 
while anti-inflammatory genes balance the 
inflammatory response, and any disruption in this 
pathway may lead to chronic inflammation and induce 
various inflammatory diseases, including MS.44,45 
Several studies have reported that hBD-234,35 and 
LL-3734,36,37 have increased in response to acute 
exercise. However, no study has investigated the 
effects of chronic exercise training on hBD-2. 
Nevertheless, two studies have reported that the 
excessive expression of hBD-2 and LL-37 may be 
associated with autoimmune diseases.12,13 
As far as we know, there is no report on the chronic 
effect of exercise on the LL-37. Only in a study, LL-37 
expression acutely was up-regulated after an exercise 
session in the experienced cyclists.46 It has been 
reported that 10 μg/mL of LL-37 during the 
differentiation of monocytes into macrophages induces 
a pro-inflammatory response.13 Moreover, neutralizing 
the TLR-4 activation through lipopolysaccharide, 
down-modulating the responses of inflammatory 
cytokines, and preventing the invasion and 
inflammatory responses to pathogenic bacteria, are 
among the LL-37 strong anti-inflammatory effects.13 
Accordingly, the unchanged LL-37 expression levels in 
the present study (in the CT group), may be considered 
as an anti-inflammatory adaptation. It is worth noting 
that LL-37 affects the expression of TLR-4.47 
Therefore, the lower increase of the TLR-4 expression 
can correlate with the constant levels of LL-37 in the 
CT group. 
A review article reported that regular exercise could 
reduce the expression level of TLR-4 in patients with 
MS.1 In the present study, the TLR-4 expression in the 
CT group increased lower than that of the CON group. 
This result is consistent with some previously reported 
results, although their subjects and their exercise types 
differ from our study. In a study, the expression of 
TLR-4 decreased in inactive adults who were at high 
risk for type two diabetes (age, 52 years) after an 8-
week (10 sessions) of either high-intensity interval 
training or moderate-intensity continuous training;40 
and also in two other studies, the monocyte TLR-4 
decreased following the exercise training.39,41 Contrary 
to our research, the TLR-4 increased after two weeks of 
high-intensity interval training.38 TLRs act through the 
myeloid differentiation factor 88 (MyD88) or the 
Toll/IL-1R domain-containing IFN-inducing adapter 
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(TRIF) pathway that leads to the activation of 
downstream signaling pathways, and consequently, 
TLR activation results in the production of pro-
inflammatory and IFN inducible genes.1 
In a recent study, serum levels of miR-155 
decreased after a 6-month Tai Chi intervention in 
patients with coronary heart disease (age, 63.61 
years).48 In another recent study, the serum miR-155 
levels decreased following 12 weeks of high-intensity 
interval training in women with breast cancer (age, 49.2 
years) who have elevated miR-155 levels.49 These 
findings are consistent with our study. Recently, 
skeletal muscle miR-23b expression increased after 
four weeks of resistance training in recreationally 
active men (Age, 22.5 years), which, regardless of the 
type of subject, age, sex, and exercise training, are 
consistent with our results.50 Dysregulation of miR-326 
and miR-155 can lead to inflammation.24 The injection 
of anti-miR-326 and anti-miR-155 can decrease  
the severity of experimental autoimmune 
encephalomyelitis (EAE), and overexpression of miR-
23b reduces the disease severity.24 
Interestingly, different TLRs, including TLR-4, up-
regulate the expression levels of miR-155 in innate 
immune cells, especially in macrophages and dendritic 
cells.22,26 Higher expression of TLR-4 in the CON 
group, compared with that of the CT group, could be 
associated with increased expression of miR-155 and 
decreased expression of miR-23b in the CON group; 
because TLR-4 expression is directly related to the 
miR-155 expression33 and inversely related to the miR-
23b expression.21 
It has been reported that miR-23b plays a key role 
in the downstream signaling pathway of MyD8821. 
Increased expression of miR-23b leads to the inhibition 
of TAB2, TAB3, and IKK-α in this pathway, which 
ultimately leads to decreased levels of some 
inflammatory factors such as IL-17.21,33 
Although we did not test the effect of CT on the IL-
17 levels, it has been reported that the expression level 
of miR-23b inversely correlates with the expression of 
IL-17. In a study, the expression levels of IL-17 down-
regulated after eight weeks of CT resulted in an anti-
inflammatory effect.7 The previous reports indicated 
that IL-17A inhibits the excessive expression of miR-
23b by activating the NF-kB pathway.27 
We found no studies about the potential effects of 
exercise training on miR-326. The up-regulated 
expression of miR-326 in EAE mice leads to more 
severe EAE, as well as the increased Th17 
differentiation.25 Moreover, a previous report has 
suggested that the expression of miR-326, in T cells, 
induces Th17 differentiation by targeting the Ets1 
transcription factor (a factor involved in the negative 
regulation of differentiation into Th17).25 It seems that 
exercise training may reduce the inhibition of Ets1 via 
down-regulation of the expression of miR-326 in 
RRMS patients, which consequently may lead to the 
tendency of Th17 to differentiation. 
We found that the EDSS was significantly 
decreased in the CT group compared with the control 
group. Our result is consistent with a previous study by 
Golzari et al.7 The within-group improvement in EDSS, 
in the experimental group, may have been due to 
weight loss and improved lower body strength in 
participants, although it seems that further research 
needs to be done in this area. 
The effects of exercise training on the expression 
patterns of AMPs-associated miRs have not been 
previously investigated in patients with MS. Therefore, 
further studies are needed to be conducted to explore 
the mechanisms underlying the expression regulation of 
AMPs-associated miRs in patients with MS.   
Although the sample size was calculated based on 
the results of a previous study,7 the relatively larger 
sample size and longer duration of the intervention 
period can guarantee results in future studies. 
Our results showed that the combined training 
might improve inflammatory symptoms by affecting 
the expression of some AMPs, microRNAs, and TLR-4 
in patients with RRMS. Moreover, it seems that 
combined training may be used as a complementary 
therapeutic strategy to attenuate inflammation in MS 
patients with mild to moderate disability.  
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